This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB02139/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02139/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02139/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02139/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02139/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02139
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02139 n7:DB02139
dcterms:title
(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine
adms:identifier
n9:DB02139 n10:R04 n11:393466 n12:445990 n14:46509024
n3:IUPAC-Name
n4:271B417F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4185-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4184-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4181-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4182-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4183-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B417D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B417B-363D-11E5-9242-09173F13E4C5 n4:271B417E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B417C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B418B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B418C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4186-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4187-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4189-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4188-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B418A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4190-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4192-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4193-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B418F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B418E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4191-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4180-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B418D-363D-11E5-9242-09173F13E4C5